GPCRStructure Therapeutics Inc.

$25.51+8.2% 1Y

Is it safe?

Watch

Caution warranted: heavy debt (CCC) and big price swings.

2 to watch, 4 without data
Credit gradeCCCderived · Jun 30, 2026

Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.

Drawdown risk99% volderived · Oct 9, 2026

Large price swings, high volatility. Worst drawdown -81% · now 73% below its 52-week high.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Volatilitybottom 5% of the market
Max drawdownbehind 76% of the market

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can GPCR take a bad year?

The deepest fall in GPCR's price history on file is −81%; it is 73% below its high today.

−81%

Worst drawdown on file · −73% today

Cash runway
5+ years

Cash runway · burning $56M a quarter at the current rate

Annualised volatility
99%

Annualised volatility · three times the market's own swing

Details›
Cash and short-term investments
$1.34B
EBITDA, trailing twelve months
−$256M
Operating profit, trailing twelve months
−$258M
Annualised volatilitytwo years of daily moves
99%
Worst drawdown on file
−81%
Below its 52-week high
73%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.